Related Experiment Video
Updated: Jul 19, 2026
Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad
Published on: January 20, 2019
[The large cell anaplastic lymphoma associated with breast implants]
Virginie Van Boeckel1, Ophélie Duysinx1, Karlien Vrancken1
1Service de Chirurgie plastique et maxillo-faciale, CHU Liège, Belgique.
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare cancer. Early detection and removal of breast implants with capsulectomy are crucial for successful treatment of BIA-ALCL.
Area of Science:
- Oncology
- Immunology
- Pathology
Background:
- Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare T-cell malignancy.
- Development of BIA-ALCL involves textured implants, bacterial contamination, and genetic factors.
- NCCN provides guidelines for BIA-ALCL diagnosis and treatment.
Observation:
- A case of BIA-ALCL presented as a periprosthetic seroma.
- The patient had breast implants for 19 years.
Findings:
- Early detection of BIA-ALCL is vital for cure.
- Implant removal with total capsulectomy is the primary treatment for early-stage BIA-ALCL.
Implications:
- Highlights the importance of long-term monitoring for patients with breast implants.
- Emphasizes prompt diagnosis and surgical intervention for suspected BIA-ALCL.
- Contributes to understanding the clinical presentation and management of BIA-ALCL.
More Related Videos
06:29Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland
Published on: June 7, 2019
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
